recently featured posts we've got 70502 articles so far

Mallinckrodt sues FDA over ADHD drug; reports Q4 loss [St. Louis Post-Dispatch]

Nov19

Nov. 19Mallinckrodt Pharmaceuticals announced Wednesday it is suing the U.S. Food and Drug Administration for the agency’s "unlawful" reclassification of its attention-deficit hyperactivity disorder drug, methylphenidate ER.The drug was previously considered, and approved, as a generic version of the branded drug Concerta until a week ago. But on Nov. 13, the FDA backtracked and told […]

Injectable Drug Delivery Market: Global Industry Analysis and Forecast to 2020

Nov19

Persistence Market Research is released new forthcoming report on title “Injectable Drug Delivery Market: Global Industry Analysis and Forecast to 2020″.New York, NY (ReleaseWire) 11/19/2014 Drug delivery is a process of administering pharmaceutical compound through various routes in the body for therapeutic effect. Oral, injection based, transdermal and carrier based are some of the types […]

Clear Vision Information Systems Among Featured Speakers and Exhibitors at Healthcare Industry’s ICE Meeting December 11-12 in San Francisco

Nov19

LOS ANGELES(BUSINESS WIRE) Pam Klugman, founder and chief product officer of Clear Vision Information Systems, and Karen Bach, Clear Vision’s director of compliance and analytics, will be among the featured speakers at the annual ICE meeting December 11-12 in San Francisco. ICE is healthcare’s Industry Collaboration Effort, which brings together providers, health plans, associations, state […]

Ranbaxy Files Complaint Against FDA Over Revocation of Tentative Approvals For ANDAs For Esomeprazole Magnesium Delayed-Release Capsules And… [Global Data Point]

Nov19

Ranbaxy Files Complaint Against FDA Over Revocation of Tentative Approvals For ANDAs For Esomeprazole Magnesium Delayed-Release Capsules And Valganciclovir Hydrochloride TabletsFDA has said that its original decisions granting tentative approvals were in error because of the compliance status of the facilities referenced in the ANDAs at the time the tentative approvals were granted. As a […]

Colorado’s Health Technology Regional Extension Center Program Reaches Goals, Enables State To Be A Leader In EHR Adoption

Nov19

DENVER, Nov. 19, 2014 /PRNewswire/ CORHIO, the Colorado Regional Health Information Organization, announced today that the Colorado Regional Extension Center program completed its goal of helping 2,295 primary care providers and 33 rural and critical access hospitals adopt and meaningfully use electronic health records (EHR) technology.Of the 2,295 primary care providers that the Colorado Regional […]

PCCA Forms Nationwide Preferred Provider Network of Compounding Pharmacies to Partner With Pharmacy Benefits Managers, Health Plans and Employers

Nov19

HOUSTON, Nov. 19, 2014 /PRNewswire-USNewswire/ PCCA, the largest and most-established U.S.-based supplier of chemicals, formulas, equipment and education for compounding pharmacies, is forming PersonalMed?, a preferred provider network (PPN) of Pharmacy Compounding Accreditation Board (PCAB) Accredited PCCA member pharmacies. PersonalMed represents a strategic approach to pharmacy benefit management similar to health insurers’ preferred provider organizations […]

Axxess Pharma Receives Health Canada Approval to Sell High Potency Omega-3 Fish Oil Supplement Throughout Canada

Nov19

TORONTO, ON (Marketwired) 11/19/14 Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they have now received Health Canada approval to sell their high potency Omega-3 fish oil supplement throughout Canada. The Omega-3 fish oil will be sold under […]

Ackman’s Pershing Square Withdraws Call For Allergan Special Shareholder Meeting

Nov19

WASHINGTON (dpa-AFX) – Activist investor William Ackman’s hedge fund Pershing Square Capital Management LP has in a regulatory filing on Tuesday formally withdrawn its request for a special shareholder meeting of Botox maker Allergan, Inc. (AGN) following a windfall he made despite losing out on the deal to acquire it. The meeting was scheduled for […]

Arrowhead Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi; TapImmune Announces Phase II Clinical Trials with VGTI Florida

Nov19

Below is a look at some of the headlines for companies that made news in the healthcare sector on November 18, 2014.{nfg}Arrowhead Research Corporation (NasdaqGS: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it recently filed an application for approval to begin a Phase 1 clinical trial of its RNAi-based therapeutic candidate, […]

Researchers from Singapore National University Report on Findings in Drug Delivery Systems (Microneedle Array Integrated With CNT Nanofilters for…

Nov19

Researchers from Singapore National University Report on Findings in Drug Delivery Systems (Microneedle Array Integrated With CNT Nanofilters for Controlled and Selective Drug Delivery)By a News Reporter-Staff News Editor at Biotech Week A new study on Drugs and Therapies is now available. According to news reporting originating from Singapore, Singapore, by NewsRx correspondents, research stated, […]